Business Description
Catheter Precision Inc
NAICS : 339112
SIC : 3841
ISIN : US74933X7084
Total Employee Number:
17Description
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.04 | |||||
Equity-to-Asset | 0.27 | |||||
Debt-to-Equity | 1.25 | |||||
Debt-to-EBITDA | -0.85 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | -14.5 | |||||
Beneish M-Score | -1.98 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -35.3 | |||||
3-Year EBITDA Growth Rate | 84.8 | |||||
3-Year EPS without NRI Growth Rate | 89.4 | |||||
3-Year FCF Growth Rate | 88 | |||||
3-Year Book Growth Rate | -83.1 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 27.65 | |||||
9-Day RSI | 35.64 | |||||
14-Day RSI | 39.76 | |||||
3-1 Month Momentum % | 3.23 | |||||
6-1 Month Momentum % | -52.24 | |||||
12-1 Month Momentum % | -79.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.06 | |||||
Quick Ratio | 0.06 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 233.76 | |||||
Days Sales Outstanding | 48.69 | |||||
Days Payable | 3961.41 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -440.7 | |||||
Shareholder Yield % | -547.46 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 91.52 | |||||
Operating Margin % | -996.66 | |||||
Net Margin % | -1337.46 | |||||
EBITDA Margin % | -1280.42 | |||||
FCF Margin % | -811.01 | |||||
OCF Margin % | -790.07 | |||||
ROE % | -194.42 | |||||
ROA % | -58.44 | |||||
ROIC % | -35.61 | |||||
3-Year ROIIC % | 74.09 | |||||
ROC (Joel Greenblatt) % | -3038.52 | |||||
ROCE % | -91.21 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 0.98 | |||||
PB Ratio | 0.22 | |||||
EV-to-EBIT | -0.82 | |||||
EV-to-EBITDA | -0.94 | |||||
EV-to-Revenue | 11.97 | |||||
EV-to-Forward-Revenue | 0.02 | |||||
EV-to-FCF | -1.48 | |||||
Price-to-GF-Value | 0.46 | |||||
Earnings Yield (Greenblatt) % | -121.95 | |||||
FCF Yield % | -422.47 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with AMEX:VTAK
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Catheter Precision Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.108 | ||
| EPS (TTM) ($) | -13.633 | ||
| Beta | 0.5731 | ||
| 3-Year Sharpe Ratio | -1.74 | ||
| 3-Year Sortino Ratio | -1.67 | ||
| Volatility % | 47.03 | ||
| 14-Day RSI | 39.76 | ||
| 14-Day ATR ($) | 0.167492 | ||
| 20-Day SMA ($) | 0.993285 | ||
| 12-1 Month Momentum % | -79.29 | ||
| 52-Week Range ($) | 0.7501 - 4.94 | ||
| Shares Outstanding (Mil) | 2.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Catheter Precision Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Catheter Precision Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 131 days | ||
| Second quarter earnings results for 2026 | 2026-08-11 | In 37 days | ||
| First quarter earnings results for 2026 | 2026-05-18 | 0.76 (-8.64%) | ||
| Annual report for 2025 | 2026-03-31 | 1.05 (-1.87%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 2.31 (-2.75%) | ||
| 0.0526316:1 Stock Split | 2025-08-15 | 2.92 (-3.81%) | ||
| Second quarter earnings results for 2025 | 2025-08-11 | 3.62 (+4.67%) | ||
| First quarter earnings results for 2025 | 2025-05-14 | 5.83 (+2.33%) | ||
| Annual report for 2024 | 2025-03-31 | 6.74 (-5.69%) | ||
| Third quarter earnings results for 2024 | 2024-11-14 | 9.12 (+10.47%) |
Show
Entries
Catheter Precision Inc Frequently Asked Questions
What is Catheter Precision Inc(VTAK)'s stock price today?
The current price of VTAK is $0.79. The 52 week high of VTAK is $4.94 and 52 week low is $0.75.
When is next earnings date of Catheter Precision Inc(VTAK)?
The next earnings date of Catheter Precision Inc(VTAK) is 2026-08-11 Est..
Does Catheter Precision Inc(VTAK) pay dividends? If so, how much?
Catheter Precision Inc(VTAK) does not pay dividend.
Guru Commentaries on AMEX:VTAK
No articles.
Press Release
Articles on Catheter Precision Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers